相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Crambescidin 800, Isolated from the Marine Sponge Monanchora viridis, Induces Cell Cycle Arrest and Apoptosis in Triple-Negative Breast Cancer Cells
Sumi Shrestha et al.
MARINE DRUGS (2018)
Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group
Paola Perego et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Dual Inhibition of Key Proliferation Signaling Pathways in Triple-Negative Breast Cancer Cells by a Novel Derivative of Taiwanin A
Yueh-Hsiung Kuo et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Stellettin B induces apoptosis in human chronic myeloid leukemia cells via targeting PI3K and Stat5
Yali Chen et al.
ONCOTARGET (2017)
Anti-proliferation of triple-negative breast cancer cells with physagulide P: ROS/JNK signaling pathway induces apoptosis and autophagic cell death
Pei Yu et al.
ONCOTARGET (2017)
FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer
L. Marzi et al.
BRITISH JOURNAL OF CANCER (2016)
Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases
Per Hydbring et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer
Abderrahim El Guerrab et al.
ONCOTARGET (2016)
Stellettin B Induces G1 Arrest, Apoptosis and Autophagy in Human Non-small Cell Lung Cancer A549 Cells via Blocking PI3K/Akt/mTOR Pathway
Ran Wang et al.
SCIENTIFIC REPORTS (2016)
Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells
Tomonori Tanei et al.
BREAST CANCER RESEARCH (2016)
Ziyuglycoside I Inhibits the Proliferation of MDA-MB-231 Breast Carcinoma Cells through Inducing p53-Mediated G2/M Cell Cycle Arrest and Intrinsic/Extrinsic Apoptosis
Xue Zhu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Cyproheptadine, an antihistaminic drug, inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase
Yu-Min Feng et al.
BMC CANCER (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
The re-emergence of natural products for drug discovery in the genomics era
Alan L. Harvey et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease
Murugan Kalimutho et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Isoliensinine induces apoptosis in triple-negative human breast cancer cells through ROS generation and p38 MAPK/JNK activation
Xiyu Zhang et al.
SCIENTIFIC REPORTS (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
New Strategies for Triple-Negative Breast Cancer-Deciphering the Heterogeneity
Ingrid A. Mayer et al.
CLINICAL CANCER RESEARCH (2014)
In Vitro Antitumor Activity of Stellettin B, a Triterpene from Marine Sponge Jaspis stellifera, on Human Glioblastoma Cancer SF295 Cells
Sheng-An Tang et al.
MARINE DRUGS (2014)
Marine Sponge Derived Natural Products between 2001 and 2010: Trends and Opportunities for Discovery of Bioactives
Mohammad Ferdous Mehbub et al.
MARINE DRUGS (2014)
Methotrexate Inhibits NF-κB Activity Via Long Intergenic (Noncoding) RNA-p21 Induction
Charles F. Spurlock et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Modulation of Sensitivity to Antitumor Agents by Targeting the MAPK Survival Pathway
Giacomo Cossa et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Cdks, cyclins and CKIs: roles beyond cell cycle regulation
Shuhui Lim et al.
DEVELOPMENT (2013)
Hinokitiol Inhibits Cell Growth through Induction of S-Phase Arrest and Apoptosis in Human Colon Cancer Cells and Suppresses Tumor Growth in a Mouse Xenograft Experiment
Youn-Sun Lee et al.
JOURNAL OF NATURAL PRODUCTS (2013)
Finding chemo: the search for marine-based pharmaceutical drugs active against cancer
Sivanjah Indumathy et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells
Anabel Sorolla et al.
MOLECULAR ONCOLOGY (2012)
Aurantoside K, a New Antifungal Tetramic Acid Glycoside from a Fijian Marine Sponge of the Genus Melophlus
Rohitesh Kumar et al.
MARINE DRUGS (2012)
Fisetin, a Dietary Flavonoid, Induces Cell Cycle Arrest and Apoptosis through Activation of p53 and Inhibition of NF-Kappa B Pathways in Bladder Cancer Cells
Jing Li et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
Akt, FoxO and regulation of apoptosis
Xinbo Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer
Heather L. McArthur et al.
CANCER (2011)
Deconstructing the molecular portraits of breast cancer
Aleix Prat et al.
MOLECULAR ONCOLOGY (2011)
Aurantoside J: a New Tetramic Acid Glycoside from Theonella swinhoei. Insights into the Antifungal Potential of Aurantosides
Rihab F. Angawi et al.
MARINE DRUGS (2011)
Triple-Negative Breast Cancer: An Unmet Medical Need
Clifford A. Hudis et al.
ONCOLOGIST (2011)
Marine Natural Products Chemistry: Past, Present, and Future
Robert J. Capon
AUSTRALIAN JOURNAL OF CHEMISTRY (2010)
Triple-negative breast cancer: Present challenges and new perspectives
Franca Podo et al.
MOLECULAR ONCOLOGY (2010)
Molecular Stratification of Triple-Negative Breast Cancers
Charles M. Perou
ONCOLOGIST (2010)
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat et al.
BREAST CANCER RESEARCH (2010)
Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer
B. Corkery et al.
ANNALS OF ONCOLOGY (2009)
Constitutive activation of nuclear factor-kappa B is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines
Noritaka Yamaguchi et al.
CANCER SCIENCE (2009)
DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation
Lei Wang et al.
CANCER SCIENCE (2009)
Cell cycle, CDKs and cancer: a changing paradigm
Marcos Malumbres et al.
NATURE REVIEWS CANCER (2009)
Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype
Maggie C. U. Cheang et al.
CLINICAL CANCER RESEARCH (2008)
Natural products in drug discovery
Alan L. Harvey
DRUG DISCOVERY TODAY (2008)
Increased phosphorylation of Akt in triple-negative breast cancers
Shinobu Umemura et al.
CANCER SCIENCE (2007)
A gene transcription signature of the Akt/mTOR pathway in clinical breast tumors
C. J. Creighton
ONCOGENE (2007)
Exploiting the PI3K/AKT pathway for cancer drug discovery
BT Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Promoting apoptosis as a strategy for cancer drug discovery
SW Fesik
NATURE REVIEWS CANCER (2005)
Cyclin D1 induction through IκB kinase β/nuclear factor-κB pathway is responsible for arsenite-induced increased cell cycle G1-S phase transition in human keratinocytes
WM Ouyang et al.
CANCER RESEARCH (2005)
Activated AKT regulates NF-κB activation, p53 inhibition and cell survival in HTLV-1-transformed cells
SJ Jeong et al.
ONCOGENE (2005)
Marine sponges as pharmacy
D Sipkema et al.
MARINE BIOTECHNOLOGY (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Aurantosides G, H, and I: Three new tetramic acid glycosides from a Papua New Guinea Theonella swinhoei
AS Ratnayake et al.
JOURNAL OF NATURAL PRODUCTS (2005)
Mitogen-activated protein kinases in apoptosis regulation
T Wada et al.
ONCOGENE (2004)
NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression
MA Huber et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
NF-KB activation in human breast cancer specimens and its role in cell proliferation and apoptosis
DK Biswas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Role of the p38 MAPK pathway in cisplatin-based therapy
JH Losa et al.
ONCOGENE (2003)
Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells
A Mansouri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The stress-activated protein kinases p38α and JNK1 stabilize p21Cip1 by phosphorylation
GY Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor
HK Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Proliferation, cell cycle and apoptosis in cancer
GI Evan et al.
NATURE (2001)
Marine organisms as a source of new anticancer agents
Gilberto Schwartsmann et al.
LANCET ONCOLOGY (2001)
Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells
BHP Zhou et al.
NATURE CELL BIOLOGY (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
